| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Molecular and Cell Biology and Cancer Research Laboratory, University of California at Berkeley, Berkeley, California 94720 [T-P. L., R. C. G., R. C. O., S. N.], and Division of Biology, University of California at Santa Cruz, Santa Cruz, California 95064 [G. T.]
The Wnt-1 proto-oncogene is transcriptionally activated by mouse mammary tumor virus in mouse mammary tumor virus-induced tumors. Previous studies using transgenic mice showed that Wnt-1 expression in mammary gland causes alveolar hyperplasias which resemble mammary glands of pregnant mice. To understand the role of mammogenic hormones in the genesis of these hyperplasias, we examined the development of these glands before puberty in young transgenic mice and the effects of ovariectomy and adrenalectomy on the growth and morphology of Wnt-1 mammary hyperplasia. Mammary glands of Wnt-1 transgenic females showed hyperplastic morphology as early as 1 week after birth. The normal structure of the uterus of the adult Wnt-1 virgin mouse indicated that the circulating levels of ovarian hormones were not elevated. Ovariectomy and adrenalectomy had no obvious effect on the morphology of these mammary hyperplasias. To assess possible paracrine stimulation of mammary epithelial cells (MEC) by stromal cells, we transplanted MEC from normal BALB/c mice into gland-free fat pads of Wnt-1 transgenic mice and found that normal MEC maintained their normal ductal structure in Wnt-1 fat pads without alveolar development. Further, we did not detect Wnt-1 mRNA expression in the gland-free fat pads of these transgenic mice. When Wnt-1 MEC were transplanted into the fat pads of nude mice and allowed to grow towards existing normal MEC, the morphology of the existing normal MEC remained normal. We concluded that the development of mammary hyperplasia in Wnt-1 transgenic mice is solely dependent on Wnt-1 expression in MEC. We speculate that Wnt-1 may be a growth factor for mammary gland that only acts locally on the cells that produce it.
1 This study was supported by NIH Grant CA 05388.
2 To whom requests for reprints should be addressed, at 491 LSA, Cancer Research Laboratory, University of California, Berkeley, Berkeley, CA 94720.
Received 1/27/92. Accepted 6/ 4/92.
This article has been cited by other articles:
![]() |
E. L. Milliken, R. K. Ameduri, M. D. Landis, A. Behrooz, F. W. Abdul-Karim, and R. A. Keri Ovarian Hyperstimulation by LH Leads to Mammary Gland Hyperplasia and Cancer Predisposition in Transgenic Mice Endocrinology, September 1, 2002; 143(9): 3671 - 3680. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fukuhara, M. Kariya, M. Kita, H. Shime, T. Kanamori, C. Kosaka, A. Orii, J. Fujita, and S. Fujii Secreted Frizzled Related Protein 1 Is Overexpressed in Uterine Leiomyomas, Associated with a High Estrogenic Environment and Unrelated to Proliferative Activity J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1729 - 1736. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Naylor, M. Smalley, D Robertson, B. Gusterson, P. Edwards, and T. Dale Retroviral expression of Wnt-1 and Wnt-7b produces different effects in mouse mammary epithelium J. Cell Sci., January 6, 2000; 113(12): 2129 - 2138. [Abstract] [PDF] |
||||
![]() |
P. Fedi, A. Bafico, A. N. Soria, W. H. Burgess, T. Miki, D. P. Bottaro, M. H. Kraus, and S. A. Aaronson Isolation and Biochemical Characterization of the Human Dkk-1 Homologue, a Novel Inhibitor of Mammalian Wnt Signaling J. Biol. Chem., July 2, 1999; 274(27): 19465 - 19472. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bafico, A. Gazit, T. Pramila, P. W. Finch, A. Yaniv, and S. A. Aaronson Interaction of Frizzled Related Protein (FRP) with Wnt Ligands and the Frizzled Receptor Suggests Alternative Mechanisms for FRP Inhibition of Wnt Signaling J. Biol. Chem., June 4, 1999; 274(23): 16180 - 16187. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. P. Bocchinfuso, W. P. Hively, J. F. Couse, H. E. Varmus, and K. S. Korach A Mouse Mammary Tumor Virus-Wnt-1 Transgene Induces Mammary Gland Hyperplasia and Tumorigenesis in Mice Lacking Estrogen Receptor-{{alpha}} Cancer Res., April 1, 1999; 59(8): 1869 - 1876. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Humphreys, J. Lydon, B. W. OMalley, and J. M. Rosen Mammary Gland Development Is Mediated by Both Stromal and Epithelial Progesterone Receptors Mol. Endocrinol., June 1, 1997; 11(6): 801 - 811. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |